VOLUME 61   2000   NUMBER 4

Brainstorms

242 The 7 Habits of Highly Effective Psychopharmacologists: Overview. Stephen M. Stahl
[PDF]

Original Articles

244 Prevalence of Attention-Deficit/Hyperactivity Disorder and Conduct Disorder Among Substance Abusers. Howard Schubiner, Angela Tzelepis, Sharon Milberger, Nancy Lockhart, Michael Kruger, Bobbe J. Kelley, and Eugene P. Schoener
[Abstract] [PDF]

252 Pharmacokinetics, Tolerability, and Clinical Effectiveness of Quetiapine Fumarate: An Open-Label Trial in Adolescents With Psychotic Disorders. Brian J. McConville, Lisa A. Arvanitis, Per T. Thyrum, Chiao Yeh, Lisa A. Wilkinson, Robert O. Chaney, Keith D. Foster, Michael T. Sorter, Loren M. Friedman, Kerri L. Brown, and James E. Heubi
[Abstract] [PDF]

261 Recurrent Cases of Corticosteroid-Induced Mood Disorder: Clinical Characteristics and Treatment. Ken Wada, Norihito Yamada, Hiroshi Suzuki, Yomei Lee, and Shigetoshi Kuroda
[Abstract] [PDF]

268 Social Functioning in Depression: A Review. Robert M. A. Hirschfeld, Stuart A. Montgomery, Martin B. Keller, Siegfried Kasper, Alan F. Schatzberg, Hans-Jurgen Moller, David Healy, David Baldwin, Mats Humble, Marcio Versiani, Roger Montenegro, and Marc Bourgeois
[Abstract] [PDF]

276 Antidepressant-Induced Sexual Dysfunction During Treatment With Moclobemide, Paroxetine, Sertraline, and Venlafaxine. Sidney H. Kennedy, Beata S. Eisfeld, Susan E. Dickens, Jason R. Bacchiochi, and R. Michael Bagby
[Abstract] [PDF]

282 Nefazodone and the Treatment of Nonparaphilic Compulsive Sexual Behavior: A Retrospective Study. Eli Coleman, Thomas Gratzer, Leon Nesvacil, and Nancy C. Raymond
[Abstract] [PDF]

285 Combined Treatment With Venlafaxine and Tricyclic Antidepressants in Depressed Patients Who Had Partial Response to Clomipramine or Imipramine: Initial Findings. Jose Ma Gomez Gomez and Cristina Teixido Perramon
[Abstract] [PDF]

290 One-Year Costs of Second-Line Therapies for Depression. Erin M. Sullivan, Robert I. Griffiths, Richard G. Frank, Michael J. Strauss, Robert J. Herbert, Jon Clouse, and Howard H. Goldman
[Abstract] [PDF]

Academic Highlights

307 New Insights Into Genetics and Pathophysiology of Alzheimer's Disease: What Are the Clinical and Therapeutic Implications?
[PDF]

CME Article 316

317 Explanatory Therapy in Hypochondriasis. Giovanni A. Fava, Silvana Grandi, Chiara Rafanelli, Stefania Fabbri, and Manuela Cazzaro
[Abstract] [PDF]

Letters to the Editor

299 Special Thanks. Alan J. Gelenberg
[PDF]

299 Schizophrenia-Associated Idiopathic Unconjugated Hyperbilirubinemia (Gilbert's Syndrome): 3 Case Reports. Tsuyoshi Miyaoka, Haruo Seno, Takahiro Maeda, Motoi Itoga, and Jun Horiguchi
[PDF]

300 Effectiveness of Risperidone in Simple Schizophrenia: A Single Case Report. Shigehiro Hirose
[PDF]

301 Citalopram and Clozapine: Potential Drug Interaction. Christina P. Borba and David C. Henderson
[PDF]

302 Gastrointestinal Adverse Effects With Divalproex Sodium and Valproic Acid. Peter G. Wagner, Steven R. Welton, and Constance M. Hammond
[PDF]

  • Reply by Carlos A. Zarate, Jr.

303 Misuse of the Term Phenomenology. Michael Alan Schwartz
[PDF]

304 Low-Dose Lithium Augmentation of Divalproex in Geriatric Mania. Joseph F. Goldberg, Michael H. Sacks, and James H. Kocsis
[PDF]

Book Reviews 305

Information for authors

see January 2000, pages 58-60 or our Web site at www.psychiatrist.com/author.htm